Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
60,213
-0.01%
|
$62,320,455
$1035.01 P/Share
|
|
Nov 17
2025
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+6.18%
|
$219,515
$1021.7 P/Share
|
|
Nov 17
2025
|
Jon R Moeller Director |
BUY
Grant, award, or other acquisition
|
Direct |
233
+43.39%
|
$237,893
$1021.7 P/Share
|
|
Nov 17
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
219
+3.47%
|
$223,599
$1021.7 P/Share
|
|
Nov 17
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
224
+0.15%
|
$228,704
$1021.7 P/Share
|
|
Nov 17
2025
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+0.98%
|
$219,515
$1021.7 P/Share
|
|
Nov 17
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+0.68%
|
$233,809
$1021.7 P/Share
|
|
Nov 17
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
224
+4.6%
|
$228,704
$1021.7 P/Share
|
|
Nov 17
2025
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+2.18%
|
$219,515
$1021.7 P/Share
|
|
Nov 17
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
226
+0.2%
|
$230,746
$1021.7 P/Share
|
|
Nov 17
2025
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+0.91%
|
$219,515
$1021.7 P/Share
|
|
Nov 17
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
9,886
-0.01%
|
$10,182,580
$1030.99 P/Share
|
|
Nov 14
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
178,295
-0.05%
|
$92,080,274,455
$516449.12 P/Share
|
|
Nov 13
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
46,606
-0.03%
|
$48,004,180
$1030.99 P/Share
|
|
Nov 13
2025
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-26.05%
|
$1,010,000
$1010.5 P/Share
|
|
Nov 12
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
305,000
-0.02%
|
$308,355,000
$1011.53 P/Share
|
|
Nov 11
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
283,131
-0.01%
|
$278,884,035
$985.92 P/Share
|
|
Nov 10
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
16,869
-0.01%
|
$16,413,537
$973.3 P/Share
|
|
Nov 10
2025
|
Daniel Skovronsky EVP, CS&PO & Pres. LRL |
SELL
Bona fide gift
|
Direct |
179
-0.13%
|
-
|
|
Nov 10
2025
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
24,750
-4.58%
|
-
|
|
Nov 05
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
219,474
-0.01%
|
$205,208,190
$935.31 P/Share
|
|
Nov 04
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
526
-0.0%
|
$478,660
$910.72 P/Share
|
|
Nov 03
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
300,000
-0.01%
|
$266,700,000
$889.35 P/Share
|
|
Oct 31
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
301,342
-0.04%
|
$260,962,172
$866.02 P/Share
|
|
Oct 20
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.22%
|
$4,848
$808.96 P/Share
|
|
Oct 20
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.59%
|
$9,696
$808.96 P/Share
|
|
Oct 20
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.11%
|
$14,544
$808.96 P/Share
|
|
Oct 20
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.03%
|
$11,312
$808.96 P/Share
|
|
Oct 20
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$9,696
$808.96 P/Share
|
|
Oct 10
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,658
-0.0%
|
$3,153,196
$862.86 P/Share
|
|
Oct 09
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
10,602
-0.0%
|
$9,032,904
$852.81 P/Share
|
|
Oct 08
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
101,420
-0.01%
|
$86,409,840
$852.1 P/Share
|
|
Oct 07
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
26,795
-0.03%
|
$22,722,160
$848.01 P/Share
|
|
Oct 06
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
161,183
-0.02%
|
$137,327,916
$852.07 P/Share
|
|
Oct 03
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
192,404
-0.01%
|
$160,464,936
$834.94 P/Share
|
|
Oct 02
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
112,596
-0.01%
|
$93,004,296
$826.99 P/Share
|
|
Oct 01
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
351,015
-0.01%
|
$282,216,060
$804.45 P/Share
|
|
Sep 30
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
113,694
-0.03%
|
$86,862,216
$764.75 P/Share
|
|
Sep 19
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
23,665
-0.01%
|
$18,056,395
$763.76 P/Share
|
|
Sep 18
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
106,626
-0.02%
|
$81,568,890
$765.38 P/Share
|
|
Sep 15
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.22%
|
$4,488
$748.19 P/Share
|
|
Sep 15
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,220
$748.19 P/Share
|
|
Sep 15
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$9,724
$748.19 P/Share
|
|
Sep 15
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.64%
|
$9,724
$748.19 P/Share
|
|
Sep 15
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,212
$748.19 P/Share
|
|
Sep 05
2025
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
SELL
Bona fide gift
|
Direct |
17
-0.04%
|
-
|
|
Aug 28
2025
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-20.67%
|
$734,000
$734.93 P/Share
|
|
Aug 18
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.02%
|
$9,772
$698.05 P/Share
|
|
Aug 18
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.7%
|
$9,772
$698.05 P/Share
|
|
Aug 18
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.13%
|
$14,658
$698.05 P/Share
|